The US Food and Drug Administration (FDA) has approved Neuspera Medical’s integrated sacral neuromodulation (iSNM) system for ...

Penumbra stands to maintain its market lead and possibly increase its market share as the purchasing of the Ruby XL system ...

GeneCentric Therapeutics has secured $8m in new funding to accelerate the development of its RNA-based liquid biopsy platform ...

PharmaSens and SiBionics have entered a development partnership for niia signature, an all-in-one wearable device.

The European Commission (EC) will restrict Chinese firms from EU government purchases of medical devices exceeding €5m ($5.7m ...

Altum Sequencing has developed a tool that uses a simple blood sample for monitoring treatment response in individuals with ...

GE HealthCare has announced the renewal of its research partnership with Stanford Medicine, US, focusing on the PET/CT ...

Beset by seemingly endless responsibilities, within the UK's NHS and other healthcare systems globally, burnout among GPs is ...

GeneCentric Therapeutics has secured $8m in a Series C funding round for its comprehensive liquid biopsy testing system, ...

Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid ...

Grail has reported encouraging top-line performance and safety outcomes from its registrational PATHFINDER 2 study’s ...

Qiagen, Incyte have announced a master collaboration agreement to create a diagnostic panel to aid in the treatment of ...